Fortekor vet 20 mg Norsko - norština - Statens legemiddelverk

fortekor vet 20 mg

elanco gmbh - benazeprilhydroklorid - tablett - 20 mg

Fortekor vet 2.5 mg Norsko - norština - Statens legemiddelverk

fortekor vet 2.5 mg

elanco gmbh - benazeprilhydroklorid - tablett - 2.5 mg

Fortekor vet 5 mg Norsko - norština - Statens legemiddelverk

fortekor vet 5 mg

elanco gmbh - benazeprilhydroklorid - tablett - 5 mg

Heparin Leo 100 IE/ ml Norsko - norština - Statens legemiddelverk

heparin leo 100 ie/ ml

leo pharma - heparinnatrium - injeksjonsvæske, oppløsning - 100 ie/ ml

Heparin Leo 5000 IE/ ml Norsko - norština - Statens legemiddelverk

heparin leo 5000 ie/ ml

leo pharma - heparinnatrium - injeksjonsvæske, oppløsning - 5000 ie/ ml

Steglatro Evropská unie - norština - EMA (European Medicines Agency)

steglatro

merck sharp & dohme b.v. - ertugliflozin l-pyroglutamic syre - diabetes mellitus, type 2 - drugs used in diabetes, sodium-glucose co-transporter 2 (sglt2) inhibitors - steglatro er indisert hos voksne i alderen 18 år og eldre med type 2 diabetes mellitus som et tillegg til diett og trening for å bedre glykemisk kontroll:som monoterapi hos pasienter som bruk av metformin er ansett som upassende på grunn av intoleranse eller kontraindikasjoner. i tillegg til andre legemidler for behandling av diabetes.

Theo-Dur 200 mg Norsko - norština - Statens legemiddelverk

theo-dur 200 mg

karo pharma ab (1) - teofyllin - depottablett - 200 mg

Theo-Dur 300 mg Norsko - norština - Statens legemiddelverk

theo-dur 300 mg

karo pharma ab (1) - teofyllin - depottablett - 300 mg

Imfinzi Evropská unie - norština - EMA (European Medicines Agency)

imfinzi

astrazeneca ab - durvalumab - karsinom, ikke-småcellet lunge - antineoplastiske midler - non-small cell lung cancer (nsclc)imfinzi as monotherapy is indicated for the treatment of locally advanced, unresectable non small cell lung cancer (nsclc) in adults whose tumours express pd-l1 on ≥ 1% of tumour cells and whose disease has not progressed following platinum based chemoradiation therapy (see section 5. imfinzi in combination with tremelimumab and platinum-based chemotherapy is indicated for the first-line treatment of adults with metastatic nsclc with no sensitising egfr mutations or alk positive mutations. small cell lung cancer (sclc)imfinzi in combination with etoposide and either carboplatin or cisplatin is indicated for the first-line treatment of adults with extensive-stage small cell lung cancer (es-sclc). biliary tract cancer (btc)imfinzi in combination with gemcitabine and cisplatin is indicated for the first line treatment of adults with unresectable or metastatic biliary tract cancer (btc). hepatocellular carcinoma (hcc)imfinzi in combination with tremelimumab is indicated for the first line treatment of adults with advanced or unresectable hepatocellular carcinoma (hcc).

Tralieve Vet 50 mg/ ml Norsko - norština - Statens legemiddelverk

tralieve vet 50 mg/ ml

dechra regulatory b.v. - tramadolhydroklorid - injeksjonsvæske, oppløsning - 50 mg/ ml